Cargando…

Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice

Fibrosis refers to the accumulation of excess extracellular matrix (ECM) components and represents a key feature of many chronic inflammatory diseases. Unfortunately, no currently available treatments specifically target this important pathogenic mechanism. MicroRNAs (miRNAs) are short, non-coding R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knabel, Matthew K., Ramachandran, Kalyani, Karhadkar, Sunil, Hwang, Hun-Way, Creamer, Tyler J., Chivukula, Raghu R., Sheikh, Farooq, Clark, K. Reed, Torbenson, Michael, Montgomery, Robert A., Cameron, Andrew M., Mendell, Joshua T., Warren, Daniel S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414421/ https://www.ncbi.nlm.nih.gov/pubmed/25923107 http://dx.doi.org/10.1371/journal.pone.0124411

Ejemplares similares

Systemic scAAV9 variant mediates brain transduction in newborn rhesus macaques
por: Dehay, Benjamin, et al.
Publicado: (2012)

Nonclinical Safety Evaluation of scAAV8-RLBP1 for Treatment of RLBP1 Retinitis Pigmentosa
por: MacLachlan, Timothy K., et al.
Publicado: (2017)

Targeting the Root Cause of Mucopolysaccharidosis IIIA with a New scAAV9 Gene Replacement Vector
por: Bobo, Tierra A., et al.
Publicado: (2020)

scAAV-Mediated Gene Transfer of Interleukin 1-Receptor Antagonist to Synovium and Articular Cartilage in Large Mammalian Joints
por: Watson, Rachael S., et al.
Publicado: (2012)

Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization
por: Wang, Haibo, et al.
Publicado: (2016)

Bone-Targeted Alkaline Phosphatase Treatment of Mandibular Bone and Teeth in Lethal Hypophosphatasia via an scAAV8 Vector
por: Ikeue, Ryo, et al.
Publicado: (2018)

Characterization of hepatic macrophages and evaluation of inflammatory response in heme oxygenase-1 deficient mice exposed to scAAV9 vectors
por: Tomczyk, Mateusz, et al.
Publicado: (2020)

Optimal Inhibition of Choroidal Neovascularization by scAAV2 with VMD2 Promoter-driven Active Rap1a in the RPE
por: Wang, Haibo, et al.
Publicado: (2019)

scAAV2-Mediated C3 Transferase Gene Therapy in a Rat Model with Retinal Ischemia/Reperfusion Injuries
por: Tan, Junkai, et al.
Publicado: (2020)

Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping
por: Goyenvalle, Aurélie, et al.
Publicado: (2012)

C3 Transferase-Expressing scAAV2 Transduces Ocular Anterior Segment Tissues and Lowers Intraocular Pressure in Mouse and Monkey
por: Tan, Junkai, et al.
Publicado: (2019)

Investigating Immune Responses to the scAAV9-HEXM Gene Therapy Treatment in Tay–Sachs Disease and Sandhoff Disease Mouse Models
por: Kot, Shalini, et al.
Publicado: (2021)

Intracisternal delivery of NFκB-inducible scAAV2/9 reveals locoregional neuroinflammation induced by systemic kainic acid treatment
por: Bockstael, Olivier, et al.
Publicado: (2014)

Efficacy and biodistribution analysis of intracerebroventricular administration of an optimized scAAV9-SMN1 vector in a mouse model of spinal muscular atrophy
por: Armbruster, Nicole, et al.
Publicado: (2016)

Targeting Root Cause by Systemic scAAV9-hIDS Gene Delivery: Functional Correction and Reversal of Severe MPS II in Mice
por: Fu, Haiyan, et al.
Publicado: (2018)

Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy
por: Borrás, Teresa, et al.
Publicado: (2016)

Long-term Expression of Apolipoprotein B mRNA-specific Hammerhead Ribozyme via scAAV8.2 Vector Inhibits Atherosclerosis in Mice
por: Nischal, Hersharan, et al.
Publicado: (2013)

Functional correction of neurological and somatic disorders at later stages of disease in MPS IIIA mice by systemic scAAV9-hSGSH gene delivery
por: Fu, Haiyan, et al.
Publicado: (2016)

scAAV2-Mediated Expression of Thioredoxin 2 and C3 Transferase Prevents Retinal Ganglion Cell Death and Lowers Intraocular Pressure in a Mouse Model of Glaucoma
por: Kim, Hee Jong, et al.
Publicado: (2023)

AAV1.NT-3 Gene Therapy for Charcot–Marie–Tooth Neuropathy
por: Sahenk, Zarife, et al.
Publicado: (2014)

Homologous Recombination Mediates Functional Recovery of Dysferlin Deficiency following AAV5 Gene Transfer
por: Grose, William E., et al.
Publicado: (2012)

AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models
por: Sondergaard, Patricia C, et al.
Publicado: (2015)

Notes on Carbon Tetrachloride as an Anthelmintic
por: Chandler, Asa C., et al.
Publicado: (1925)

Carbon Tetrachloride in the Treatment of Tænia Infections
por: Maplestone, P. A., et al.
Publicado: (1931)

Carbon Tetrachloride, Merck
por: Merck, E.
Publicado: (1930)

AAV serotype 8-mediated liver specific GNMT expression delays progression of hepatocellular carcinoma and prevents carbon tetrachloride-induced liver damage
por: Fang, Cheng-Chieh, et al.
Publicado: (2018)

Surface Coupling of Octaethylporphyrin with Silicon Tetrachloride
por: Chambers, Phillip C., et al.
Publicado: (2019)

Intrathecal sc-AAV9-CB-GFP: Systemic Distribution Predominates Following Single-Dose Administration in Cynomolgus Macaques
por: Meseck, Emily K., et al.
Publicado: (2022)

Room Temperature Reduction of Titanium Tetrachloride-Activated Nitriles to Primary Amines with Ammonia-Borane
por: Ramachandran, P. Veeraraghavan, et al.
Publicado: (2022)

Safety and Efficacy of AAV Retrograde Pancreatic Ductal Gene Delivery in Normal and Pancreatic Cancer Mice
por: Quirin, Kayla A., et al.
Publicado: (2017)

scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution
por: Öztürk, Bilge E, et al.
Publicado: (2021)

Preparation of Trichloride and Tetrachloride of Molybdenum
por: Couch, Dwight E., et al.
Publicado: (1959)

Carbon Tetrachloride in Pharmacology and Therapeutics
por: Chopra, R. N., et al.
Publicado: (1923)

A Test for Carbon Tetrachloride
por: Urchs, O.
Publicado: (1930)

Notes on the Use of Carbon Tetrachloride
por: Nag, S. C.
Publicado: (1929)

AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy
por: Ising, Christina, et al.
Publicado: (2017)

AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy
por: Yalvac, M E, et al.
Publicado: (2016)

Rational Design of AAV-rh74, AAV3B, and AAV8 with Limited Liver Targeting
por: Chan, Christopher, et al.
Publicado: (2023)

Liver Function Tests and Carbon Tetrachloride
por: Bose, J. P., et al.
Publicado: (1924)

Aggregation-Inhibiting scFv-Based Therapies Protect Mice against AAV1/2-Induced A53T-α-Synuclein Overexpression
por: Schlichtmann, Benjamin W., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vehj4uuim5qs363tm6lsgaihr1